{"id":13130,"date":"2026-11-12T14:42:59","date_gmt":"2026-11-12T11:42:59","guid":{"rendered":"https:\/\/grindeks.com\/?p=13130"},"modified":"2026-11-12T14:43:04","modified_gmt":"2026-11-12T11:43:04","slug":"aptauja-latvija-joprojam-ir-izplatita-pasarstesanas-kultura","status":"publish","type":"post","link":"https:\/\/grindeks.com\/lv\/aptauja-latvija-joprojam-ir-izplatita-pasarstesanas-kultura\/","title":{"rendered":"Aptauja: Latvij\u0101 joproj\u0101m ir izplat\u012bta pa\u0161\u0101rst\u0113\u0161an\u0101s kult\u016bra"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><strong>Saj\u016btot pirm\u0101s saslim\u0161anas paz\u012bmes, piem\u0113ram, saaukst\u0113\u0161an\u0101s simptomus, 38 % aptauj\u0101to Latvijas iedz\u012bvot\u0101ju s\u0101kotn\u0113ji m\u0113\u0123ina tikt gal\u0101 pa\u0161u sp\u0113kiem \u2013 izmanto m\u0101jas vai tautas metodes, nogaida, lai simptomi p\u0101riet pa\u0161i, vai ar\u012b turpina ierasto ikdienas ritmu, secin\u0101ts Baltij\u0101 liel\u0101k\u0101 farm\u0101cijas uz\u0146\u0113muma AS \u201cGrindeks\u201d un p\u0113t\u012bjuma centra \u201cNorstat Latvija\u201d veiktaj\u0101 sabiedr\u012bbas aptauj\u0101*. Savuk\u0101rt 39 % respondentu lieto m\u0101j\u0101s jau pieejam\u0101s bezrecep\u0161u z\u0101les.<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">7 % respondentu k\u0101 pirmo r\u012bc\u012bbu saslim\u0161anas gad\u012bjum\u0101 nor\u0101da do\u0161anos uz aptieku, lai ieg\u0101d\u0101tos medikamentus, bet tikpat daudz sazin\u0101\u0161anos ar \u0123imenes \u0101rstu vai \u0101rsta praksi.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">K\u0101 nor\u0101da profesore Angelika Kr\u016bmi\u0146a, infektolo\u0123e un hepatolo\u0123e, pie pirmaj\u0101m saslim\u0161anas paz\u012bm\u0113m da\u013ca iedz\u012bvot\u0101ju izv\u0113las nogaido\u0161u taktiku un vesel\u012bbas apr\u016bpes speci\u0101lista konsult\u0101ciju mekl\u0113 tikai p\u0113c simptomu att\u012bst\u012bbas. To atspogu\u013co ar\u012b aptaujas dati \u2013 uzreiz p\u0113c simptomu par\u0101d\u012b\u0161an\u0101s pie \u0101rsta vai farmaceita v\u0113r\u0161as 2 % respondentu, savuk\u0101rt 19 % vispirms nov\u0113ro simptomu dinamiku un p\u0113c tam lemj par turpm\u0101ko r\u012bc\u012bbu.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Vienas l\u012bdz divu dienu laik\u0101 profesion\u0101lu pal\u012bdz\u012bbu mekl\u0113 21 % aptauj\u0101to, 3\u20136 dienu laik\u0101 \u2013 26 %, bet aptuveni ned\u0113\u013cu nogaida 11 %. 12 % pie \u0101rsta vai farmaceita v\u0113r\u0161as tikai tad, kad vesel\u012bbas st\u0101voklis b\u016btiski pasliktin\u0101s, savuk\u0101rt 2 % nor\u0101da, ka pie \u0101rsta vai farmaceita parasti nev\u0113r\u0161as visp\u0101r.<\/p>\n\n\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\">\n<p class=\"wp-block-paragraph\">\u201c<em>Da\u013ca cilv\u0113ku cen\u0161as p\u0113c iesp\u0113jas ilg\u0101k iztikt tikai ar m\u0101jas metod\u0113m, izvairoties no t\u0101, ko pa\u0161i m\u0113dz saukt par \u201c\u0137\u012bmiju\u201d. Ta\u010du svar\u012bgi ir nevis principi\u0101li izvair\u012bties no medikamentiem, bet savlaic\u012bgi saprast, kad ar pa\u0161apr\u016bpi vairs nepietiek. Praks\u0113 redzam, ka nov\u0113lota v\u0113r\u0161an\u0101s p\u0113c profesion\u0101las pal\u012bdz\u012bbas var novest pie situ\u0101cijas pasliktin\u0101\u0161an\u0101s un nepiecie\u0161am\u012bbas \u0101rst\u0113ties slimn\u012bc\u0101. Ja da\u017eu dienu laik\u0101 st\u0101voklis neuzlabojas vai simptomi saasin\u0101s, nevajadz\u0113tu turpin\u0101t eksperiment\u0113t tikai ar pa\u0161u izv\u0113l\u0113t\u0101m metod\u0113m \u2013 ir svar\u012bgi savlaic\u012bgi konsult\u0113ties ar \u0101rstu vai farmaceitu.\u201d<\/em> &#8211; <strong>Prof. Angelika Kr\u016bmi\u0146a<\/strong><\/p>\n<\/blockquote>\n\n\n\n<p class=\"wp-block-paragraph\">Aptaujas rezult\u0101ti r\u0101da, ka m\u0101jas vai alternat\u012bvu meto\u017eu izv\u0113li visbie\u017e\u0101k nosaka v\u0113lme izvair\u012bties no medikamentu lieto\u0161anas vieglu simptomu gad\u012bjum\u0101 \u2013 to nor\u0101da 46 % respondentu. 39 % izv\u0113li pamato ar iepriek\u0161\u0113ju pozit\u012bvu pieredzi, savuk\u0101rt 35 % ar \u0161o meto\u017eu \u0113rtu un \u0101tru pieejam\u012bbu. Tre\u0161da\u013ca jeb 33 % aptauj\u0101to nor\u0101da, ka vispirms v\u0113las m\u0113\u0123in\u0101t mazin\u0101t simptomus pa\u0161u sp\u0113kiem.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">16 % respondentu m\u0101jas vai tautas metodes uzskata par dabisk\u0101k\u0101m nek\u0101 medikamentus, 12 % t\u0101s izv\u0113las zem\u0101ku izmaksu d\u0113\u013c, bet 11 % atsaucas uz \u0123imen\u0113 nostiprin\u0101t\u0101m trad\u012bcij\u0101m. 8 % gad\u012bjumu izv\u0113li ietekm\u0113 ierobe\u017eota piek\u013cuve \u0101rstam vai laika tr\u016bkums.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><br>* Aptauja veikta sadarb\u012bb\u0101 ar p\u0113t\u012bjumu centru \u201cNorstat Latvija\u201d, aptauj\u0101jot vair\u0101k nek\u0101 1000 Latvijas iedz\u012bvot\u0101ju par vi\u0146u r\u012bc\u012bbu saslim\u0161anas gad\u012bjum\u0101.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Saj\u016btot pirm\u0101s saaukst\u0113\u0161an\u0101s paz\u012bmes, 38 % Latvijas iedz\u012bvot\u0101ju s\u0101kotn\u0113ji izv\u0113las tautas metodes vai nogaid\u012b\u0161anu, bet 39 % lieto m\u0101j\u0101s pieejam\u0101s bezrecep\u0161u z\u0101les, liecina AS \u201cGrindeks\u201d un \u201cNorstat Latvija\u201d aptauja. Infektolo\u0123e prof. Angelika Kr\u016bmi\u0146a skaidro, kad pa\u0161apr\u016bpe ir pie\u013caujama un k\u0101p\u0113c ir svar\u012bgi savlaic\u012bgi v\u0113rsties pie \u0101rsta.<\/p>\n","protected":false},"author":27,"featured_media":13132,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[2],"tags":[],"class_list":["post-13130","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-jaunums"],"acf":[],"_links":{"self":[{"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/posts\/13130","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/users\/27"}],"replies":[{"embeddable":true,"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/comments?post=13130"}],"version-history":[{"count":2,"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/posts\/13130\/revisions"}],"predecessor-version":[{"id":13136,"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/posts\/13130\/revisions\/13136"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/media\/13132"}],"wp:attachment":[{"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/media?parent=13130"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/categories?post=13130"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/tags?post=13130"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}